Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Parker-Hannifin
PH
|
+$328M |
| 2 |
Microsoft
MSFT
|
+$279M |
| 3 |
Union Pacific
UNP
|
+$267M |
| 4 |
McDonald's
MCD
|
+$267M |
| 5 |
LLL
L3 Technologies, Inc.
LLL
|
+$258M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$592M |
| 2 |
Apple
AAPL
|
+$536M |
| 3 |
Amgen
AMGN
|
+$492M |
| 4 |
General Dynamics
GD
|
+$395M |
| 5 |
CSX Corp
CSX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.95% |
| 2 | Healthcare | 14.99% |
| 3 | Financials | 13.93% |
| 4 | Industrials | 13.2% |
| 5 | Consumer Discretionary | 11.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
T. Rowe Price
TROW
$25.5B
| $144M | 0.08% |
1,334,550
+1,028,737
| +336% | +$115M |
|
277
Ligand Pharmaceuticals
LGND
$5.96B
| $144M | 0.08% |
1,397,994
-67,765
| -5% | -$6.7M |
|
278
eBay
EBAY
$50.3B
| $144M | 0.08% |
3,568,732
-279,779
| -7% | -$11.6M |
|
279
Insmed
INSM
$22.7B
| $141M | 0.08% |
6,246,342
+283,136
| +5% | +$7.45M |
|
280
Jazz Pharmaceuticals
JAZZ
$16B
| $140M | 0.08% |
928,107
-1,927
| -0.2% | -$283K |
|
281
ITT
ITT
$17.7B
| $140M | 0.08% |
2,858,847
-93,823
| -3% | -$4.95M |
|
282
Western Digital
WDC
$172B
| $140M | 0.08% |
2,006,498
-1,369,029
| -41% | -$92.2M |
|
283
Verizon
VZ
$198B
| $140M | 0.08% |
2,917,450
-37,083
| -1% | -$1.86M |
|
284
D.R. Horton
DHI
$41.3B
| $139M | 0.08% |
3,174,086
+2,040,605
| +180% | +$95.2M |
|
285
American Electric Power
AEP
$72.7B
| $139M | 0.08% |
2,025,978
+281,649
| +16% | +$19M |
|
286
Vertex Pharmaceuticals
VRTX
$122B
| $139M | 0.08% |
852,241
-319,130
| -27% | -$52.1M |
|
287
Scotiabank
BNS
$106B
| $138M | 0.08% |
+2,245,395
| New | +$142M |
|
288
Globus Medical
GMED
$10.6B
| $138M | 0.08% |
2,764,845
-712,060
| -20% | -$33.5M |
|
|
ETFC
289
DELISTED
E*Trade Financial Corporation
ETFC
| $137M | 0.08% |
2,472,298
-12,961
| -0.5% | -$691K |
|
290
LKQ Corp
LKQ
$6.69B
| $137M | 0.08% |
3,604,129
+645,824
| +22% | +$26.2M |
|
291
Corning
GLW
$123B
| $136M | 0.08% |
4,882,276
-412,969
| -8% | -$12.7M |
|
292
VF Corp
VFC
$6.72B
| $136M | 0.08% |
1,949,072
+1,125,080
| +137% | +$81.4M |
|
|
CALD
293
DELISTED
Callidus Software, Inc.
CALD
| $135M | 0.08% |
3,768,920
-257,752
| -6% | -$8.81M |
|
|
AXON
294
Axon Enterprise
AXON
$42.4B
| $135M | 0.08% |
3,439,753
-201,774
| -6% | -$6.29M |
|
295
Texas Roadhouse
TXRH
$13.2B
| $135M | 0.08% |
2,332,956
-71,419
| -3% | -$4.1M |
|
|
ABMD
296
DELISTED
Abiomed Inc
ABMD
| $134M | 0.08% |
460,829
-146,314
| -24% | -$37.1M |
|
|
KSU
297
DELISTED
Kansas City Southern
KSU
| $134M | 0.08% |
1,220,706
+303,806
| +33% | +$32.9M |
|
|
ALXN
298
DELISTED
Alexion Pharmaceuticals
ALXN
| $134M | 0.08% |
1,201,429
-104,263
| -8% | -$12.5M |
|
299
Nordson
NDSN
$16.6B
| $133M | 0.08% |
978,322
+91,002
| +10% | +$12.9M |
|
300
Cedar Fair
FUN
$1.8B
| $133M | 0.08% |
2,084,325
-45,565
| -2% | -$3.01M |
|
Similar funds
Janus Henderson Group's Q1 2018 Portfolio in Review
As of Q1 2018, Janus Henderson Group held 1,432 positions worth $170B, up 3.2% from $165B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Janus Henderson Group's Q1 2018 filing shows 129 new, 552 increased, 608 reduced and 77 closed positions. Its largest new stake was Toronto Dominion Bank: 2,798,450 shares worth $159M. The largest sale was Medtronic, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q1 2018 buy was Toronto Dominion Bank: 2,798,450 shares worth $159M.
- Janus Henderson Group added most to Parker-Hannifin in Q1 2018, an estimated $328M increase.
- Janus Henderson Group's biggest Q1 2018 reduction was Apple, cutting an estimated $536M.
- Janus Henderson Group fully exited Medtronic in Q1 2018, selling an estimated $592M.
- Janus Henderson Group's ten largest holdings make up 15% of its $170B portfolio in Q1 2018.
- Janus Henderson Group opened 129 new positions and closed 77 in Q1 2018.
- Janus Henderson Group's portfolio value rose 3.2% quarter-over-quarter to $170B.
Based on Janus Henderson Group's 13F filing for Q1 2018, filed 14 May 2018.